Prevalence and covariates of masked hypertension in ischemic stroke survivors: The Norwegian Stroke in the Young Study

Blood Pressure Monitoring

Volumn 21, Issue 4, 2016, Pages 244-250

  Saeed, Sahrai ^a,b   Waje Andreassen, Ulrike ^a   Fromm, Annette ^a   Øygarden, Halvor ^b   Naess, Halvor ^a   Gerdts, Eva ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

arterial damage; carotid intima media thickness; ischemic stroke; masked hypertension; pulse wave velocity

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; ATRIAL FIBRILLATION; BLOOD PRESSURE MONITORING; BODY MASS; BRAIN ISCHEMIA; CAROTID ARTERY INJURY; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HOLTER MONITORING; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MEDICAL HISTORY; METABOLIC SYNDROME X; NORWEGIAN (PEOPLE); OBESITY; PREVALENCE; PRIORITY JOURNAL; PULSE WAVE; SURVIVOR; SYSTOLIC BLOOD PRESSURE; TONOMETRY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPLICATION; HYPERTENSION; MIDDLE AGED; MORTALITY; NORWAY; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; BRAIN ISCHEMIA; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NORWAY; PREVALENCE; STROKE; SURVIVORS;

EID: 84963945584     PISSN: 13595237     EISSN: 14735725     Source Type: Journal    
DOI: 10.1097/MBP.0000000000000190     Document Type: Article

References (31)

1. Björklund K, Lind L, Zethelius B, Andrén B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003; 107:1297-1302.
2. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of 'masked hypertension' detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342-1349.
3. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47:846-853.
4. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, et al. Prognosis of 'masked' hypertension and 'white-coat' hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46:508-515.
5. Kotsis V, Stabouli S, Toumanidis S, Papamichael C, Lekakis J, Germanidis G, et al. Target organ damage in 'white coat hypertension' and 'masked hypertension'. Am J Hypertens 2008; 21:393-399.
6. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131:564-572.
7. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al.; Task Force for the management of arterial hypertension of the European Society of Hypertension; Task Force for the management of arterial hypertension of the European Society of Cardiology. 2013 ESH/ESC Guidelines for the Management of Arterial Hypertension. Blood Press 2013; 22:193-278.
8. Hänninen MR, Niiranen TJ, Puukka PJ, Mattila AK, Jula AM. Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertens 2011; 29:1880-1888.
9. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni (PAMELA) Study). Circulation 2001; 104:1385-1392.
10. Waje-Andreassen U, Naess H, Thomassen L, Eide GE, Meijer R, Vedeler CA. Ultrasound, atherosclerosis and stroke at a young age: a cross-sectional long-term follow-up in western Norway. Eur J Neurol 2008; 15:512-519.
11. Saeed S, Waje-Andreassen U, Fromm A, Øygarden H, Kokorina MV, Naess H, Gerdts E. Early vascular aging in young and middle-aged ischemic stroke patients: the Norwegian Stroke in the Young Study. PLoS One 2014; 9:e112814.
12. Fromm A, Thomassen L, Naess H, Meijer R, Eide GE, Krakenes J, et al. The Norwegian Stroke in the Young Study (NOR-SYS): rationale and design. BMC Neurol 2013; 13:89.
13. Jain S, Namboodri KK, Kumari S, Prabhakar S. Loss of circadian rhythm of blood pressure following acute stroke. BMC Neurol 2004; 4:1.
14. Laurent S, Cockcroft J, van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
15. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005; 46:1753-1760.
16. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012; 34:290-296.
17. Perk J, de Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, et al. European guidelines on cardiovascular disease prevention in clinical practice: the fifth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Int J Behav Med 2012; 19:403-488.
18. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al.; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Followup report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26:3160-3167.
19. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-2752.
20. Diaz KM, Veerabhadrappa P, Brown MD, Whited MC, Dubbert PM, Hickson DA. Prevalence, determinants, and clinical significance of masked hypertension in a population-based sample of African American: The Jackson Heart Study. Am J Hypertens 2015; 28:900-908.
21. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006; 19:243-250.
22. Angeli F, Reboldi G, Verdecchia P. Masked hypertension: evaluation, prognosis, and treatment. Am J Hypertens 2010; 23:941-948.
23. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28:1039-1049.
24. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011; 123:2292-2333.
25. Pikula A, Beiser AS, Wang J, Himali JJ, Kelly-Hayes M, Kase CS, et al. Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study. Neurology 2015; 84:472-479.
26. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002; 40:795-796.
27. Devereux RB, de Simone G, Ganau A, Roman MJ. Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications. J Hypertens Suppl 1994; 12:117-127.
28. Nilsson PM, Lurbe E, Laurent S. The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens 2008; 26:1049-1057.
29. Fukuhara M, Arima H, Ninomiya T, Hata J, Hirakawa Y, Doi Y, et al. Whitecoat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study. Stroke 2013; 44:1512-1517.
30. Andrikou I, Tsioufis C, Dimitriadis K, Syrseloudis D, Valenti P, Almiroudi M, et al. Similar level of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparison with sustained hypertension and normotension. Blood Press Monit 2011; 16:218-223.
31. Mancia G, Bombelli M, Facchetti R, Madotto F, Qurati-Trevano F, Friz HP, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 2009; 54:226-232.